| omeprazole versus placebo | |||
| COGENT, 2009 NCT00557921 | CGT-2168 (75-mg clopidogrel with 20 mg of omeprazole) once daily versus placebo | patients requiring clopidogrel for at least 12 months, typically following non-ST-segment-elevation ACS, STEMI, or stent implantation | double blind Follow-up duration: 133 days (mean) US, Canada, Mexico, Australia, Chile, and Europe |
| OCLA, 2008 NCT00349661 | omeprazole 20 mg daily versus placebo | patients undergoing coronary artery stent implantation | double blind Follow-up duration: 7 days France |
| pantoprazole versus omeprazole | |||
| PACA, 2009 | pantoprazole 20 mg versus omeprazole 20 mg | patients undergoing coronary stenting for non–ST-segment elevation acute coronary syndrome | Follow-up duration: 1 mo |
in first
in second
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
